InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
docrew0 Free
05/13/08 1:42 PM
profile icon
docrew0 Free
05/13/08 10:40 AM
profile icon
fratboy72 Free
05/13/08 10:38 AM
profile icon
fratboy72 Free
05/13/08 10:38 AM
profile icon
docrew0 Free
05/13/08 9:31 AM
profile icon
fratboy72 Free
04/23/08 8:42 AM
profile icon
docrew0 Free
04/04/08 12:19 PM
profile icon
fratboy72 Free
04/04/08 12:08 PM
profile icon
docrew0 Free
04/03/08 12:20 PM
profile icon
fratboy72 Free
02/05/08 8:40 AM
profile icon
fratboy72 Free
02/05/08 8:38 AM
profile icon
fratboy72 Free
02/05/08 8:37 AM
profile icon
fratboy72 Free
01/24/08 8:45 AM
profile icon
fratboy72 Free
01/24/08 8:42 AM
profile icon
fratboy72 Free
01/24/08 8:41 AM
profile icon
fratboy72 Free
01/24/08 8:36 AM
profile icon
fratboy72 Free
01/23/08 9:43 AM
profile icon
fratboy72 Free
01/23/08 9:42 AM
profile icon
fratboy72 Free
01/08/08 9:06 AM
profile icon
fratboy72 Free
01/08/08 9:04 AM
profile icon
fratboy72 Free
01/04/08 3:01 PM
profile icon
fratboy72 Free
01/03/08 11:18 AM
profile icon
fratboy72 Free
01/03/08 11:17 AM
profile icon
georgejjl Free
12/23/07 1:18 AM
profile icon
fratboy72 Free
12/19/07 9:45 AM
profile icon
fratboy72 Free
12/19/07 9:44 AM
profile icon
fratboy72 Free
12/04/07 1:35 PM
profile icon
TallRob0 Free
07/18/07 2:44 AM
profile icon
biomanbaba Deceased
07/18/07 1:23 AM
profile icon
John266 Free
07/17/07 12:35 PM
profile icon
gfp927z Free
07/09/07 11:31 AM

Sirtris (SIRT) RSS Feed

Followers
1
Posters
7
Posts (Today)
0
Posts (Total)
32
Created
07/09/07
Type
Free
Moderators
Sirtris Pharmaceuticals™ (NASDAQ: SIRT) is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, including metabolic diseases such as Type 2 Diabetes. Our drug candidates are designed to mimic certain beneficial health effects of calorie restriction, without requiring a change in eating habits, by activation of sirtuins, a recently discovered class of enzymes that control the aging process. The company's headquarters are in Cambridge, Massachusetts Business Address 200 Technology Square Suite 300 Cambridge, MA 02139 Phone: 617.252.6920 Fax: 617.252.6924 http://www.sirtrispharma.com Officers *Christoph Westphal, M.D., Ph.D. (CEO and Vice Chair) *Garen Bohlin (Chief Operating Officer) *Peter Elliott, Ph.D. (Senior Vice President, Head of Development) *Michael Jirousek, Ph.D. (Senior Vice President, Research) *Paul Brannelly (Vice President, Finance) Business Description Healthcare - Biotechnology ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Latest News Releases: http://phx.corporate-ir.net/phoenix.zhtml?c=185399&p=irol-news&nyo=0 ________________________________________________________________________________________________________________________________ Share structure Authorized:..........? Outstanding:.........28.7M (as of 2/5/08) Restricted: Unknown Float: Unknown ________________________________________________________________________________________________________________________________
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
SIRT Latest News
  • No Recent News Available for this company!
New Post